BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220421
DTEND;VALUE=DATE:20220701
DTSTAMP:20260516T014342
CREATED:20220425T094247Z
LAST-MODIFIED:20220519T120013Z
UID:33903-1650499200-1656633599@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China Virtual Expo Connect
DESCRIPTION:This year CPhI & P-MEC China returns as a SMART event\, combining 2 months of online event with a 3-day in-person event to help you connect for an extended period. \n \n“Virtual Expo Connect”\, to be held from 21st April – 30th June 2022\, is the digital extension of the physical CPhI & P-MEC China event that offers an online alternative for global pharma professionals. \nPowered by PharmaSources.com\, Virtual Expo Connect builds the online platform adding valued services and infinite opportunities to connect\, learn\, trade and grow. \nTo know more visit: https://www.pharmasources.com/vec2022
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-virtual-expo-connect-2/
LOCATION:Online
ORGANIZER;CN="Informa Markets":MAILTO:Yingqi.shi@imsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220425
DTEND;VALUE=DATE:20220427
DTSTAMP:20260516T014342
CREATED:20211206T115226Z
LAST-MODIFIED:20211206T115226Z
UID:32376-1650844800-1651017599@www.pharmajournalist.com
SUMMARY:SMi’s 9th Annual Conference Pre-Filled Syringes East Coast
DESCRIPTION:SMi’s 9th Annual Conference\nPre-Filled Syringes East Coast\nMain Conference: April 25 – 26\, 2022 | Workshops: April 27\, 2022 \nSheraton Boston Hotel\, Boston\, MA\, USA \nwww.pfsamericas.com/pharmajournalistwl \nSponsors are: SCHOTT\, ZEON \nExhibitors: Owen Mumford Pharmaceutical Services\, PHC Corporation\, POLYPLASTICS- TOPAS\, Weiss-Aug Group \nDevice innovations\, connected delivery and regulatory guidance for advanced parenteral systems \nThe global pre-filled syringes market was valued at $1139.6 million in 2020 and with the rapid growth of the industry\, is expected to grow at a CAGR of 8.95% up to 2027. With that in mind\, the 9th annual Pre-Filled Syringes East Coast conference will bring together leading industry experts representing big pharma and device developers to discuss the key drivers accelerating the expansion of the industry. \nThe past year has seen significant developments in the injectables landscape with the rapid introduction and development of vaccines in response to the pandemic\, updates in regulations including the EU MDR and FDA guidance on bridging studies\, and increasing industry acceptance of connectivity to aid the user experience. As part of SMi’s leading injectable series\, the 2022 conference will provide an exclusive insight into the latest developing technologies for device design\, advances in parenteral device platforms and development\, insights into growing integration of digital health and deep dives into recent case studies on novel delivery systems. \nThis two-day agenda offers you peer-to-peer networking with Global Product Managers\, Senior PFS Engineers\, Device Testing Managers\, Heads of Late-Stage PFS Development and many more. \nVisit the website at: www.pfsamericas.com/pharmajournalistwl \nChair for 2022: \nGretchen Vandal\, Sr. Director\, Head of Global Regulatory Affairs – Devices and Combination Products\, Takeda \nGuest FDA Speaker: \n\nJohn Barr Weiner\, Associate Director for Policy and Product Classification Office\, Office of Combination Products FDA\n\n Featured 2022 Speakers Include: \n\nJoyce Zhao\, Associate Director\, Combination Product\, Takeda\nSuzette Roan\, Associate VP and Head of Global Device Regulatory Affairs\, Sanofi US\nChristine lynn lanning\, Distinguished Scientist\, Device Area Leader\, Merck\nHeather l. Guerin\, Associate Director\, Regulatory Affairs – CMC\, JanssenTieming Ruan\, Senior Director of Device Development\, Alexion Pharmaceuticals\nJohn Schalago\, Executive Director\, Senior Global Program Director Regulatory Affairs\, Novartis\nGretchen Piwinski\, Manager\, Combination Product Laboratories\, Regeneron\nMichael Song\, Associate Director\, Takeda\nDeep S Bhattacharya\, Senior Scientist\, Drug Product Development and Design\, Pfizer\n\nBENEFITS OF ATTENDING: \n\nExplore the latest developments in innovative technologies for device design accelerating the path to self-administration\nAssess the evolving regulatory landscape for pre-filled syringes and discuss approaches to work with regulators as guidance is updated\nEngage in panel discussions with industry leaders to navigate the accelerating digital health landscape for combination products and drug delivery systems\nUnderstand the landscape of delivery for novel drug products and key considerations to overcome challenges in CCI\n\nView the full agenda and speaker line-up online: www.pfsamericas.com/pharmajournalistwl \nWho should Attend: \n\nDrug-delivery developers\nMedical Device Engineers\nPrimary Packaging material designers\nSecondary packagers\nSmart device developers\nTraining device developers\nDevice-safety solution providers\nDrug developers\n\nEARLY-BIRD RATES:  \n\nBOOK BY 17th DECEMBER AND SAVE $400\nBOOK BY 31st JANUARY AND SAVE $200\nBOOK BY 28TH FEBRUARY AND SAVE $100\n\nRegistrations can be made on the event website at: www.pfsamericas.com/pharmajournalistwl
URL:https://www.pharmajournalist.com/event/smis-9th-annual-conference-pre-filled-syringes-east-coast/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:RJones@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220425
DTEND;VALUE=DATE:20220428
DTSTAMP:20260516T014342
CREATED:20211217T132942Z
LAST-MODIFIED:20211217T132942Z
UID:32542-1650844800-1651103999@www.pharmajournalist.com
SUMMARY:2nd Chronic HBV Drug Development Summit
DESCRIPTION:With a tight focus on late translational to phase II clinical progress\, the 2nd Chronic HBV Drug Development Summit returns in person as the definitive industry forum to advance combination therapy and achieve functional cure in hepatitis B virus. \nDedicated to advancing direct antiviral and immunotherapy pipelines in combination therapy paradigms\, this industry-orientated forum is timely positioned after EASL to reset standards after the latest readouts. \nFrom transformative advances in establishing synergistic combination regimens\, to navigating clinical endpoints and stopping points\, and illuminating the role of immunotherapy to attain durable functional cure\, don’t miss your chance to join the conversation. \nHarness actionable insights across 3 days of exclusive content from 20+ scientific experts including Gilead Sciences\, Vir Biotechnology\, VBI Vaccines\, Altimmune\, Drug Farm\, Replicor and many more to guide your strategic decisions and drive clinical progress. \nJoin us in Boston to forge successful industry collaborations in combination therapy for chronic HBV. \nTo know more visit: https://ter.li/o1utyk
URL:https://www.pharmajournalist.com/event/2nd-chronic-hbv-drug-development-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220425
DTEND;VALUE=DATE:20220428
DTSTAMP:20260516T014342
CREATED:20211217T154450Z
LAST-MODIFIED:20211217T154530Z
UID:32594-1650844800-1651103999@www.pharmajournalist.com
SUMMARY:Novel Format Conjugates Summit
DESCRIPTION:The inaugural Novel Format Conjugates Summit exclusively focuses on the common challenges across early research and development of next generation Non-Traditional ‘ADCs’\, or alternative format conjugates approaches for oncology and beyond. This meeting delves into the different technologies of these novel-format conjugates\, exploring how conjugation chemistry is affected for different kinds of therapeutic modalities\, and the impact an alternative format ADC has on targeting. \nAs we look to the future of drug development of novel conjugates\, you will get the chance to hear the cutting-edge science accelerating the development of Bispecific ADCs\, Radio-conjugates\, ISACs\, SMDCs\, Probody conjugates\, Liposomal drug conjugates\, Oligonucleotide conjugates and many more. \nEngage in cross-industry discussions and presentations from over 20 expert speakers across 3 unmissable days and equip yourself with the tools to develop novel format ADCs with an improved therapeutic potential so we can bring more drugs to patients of unmet needs. \nTo know more visit: https://ter.li/0811lm
URL:https://www.pharmajournalist.com/event/novel-format-conjugates-summit/
LOCATION:Omni Parker House\, 60 School St\, Boston\, MA\, 02108\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220425
DTEND;VALUE=DATE:20220428
DTSTAMP:20260516T014342
CREATED:20220125T123012Z
LAST-MODIFIED:20220125T123113Z
UID:32954-1650844800-1651103999@www.pharmajournalist.com
SUMMARY:3rd Supply Chain and Logistics for Cell Therapies Summit
DESCRIPTION:Keen to unite with your #celltherapy supply chain community and gain actionable insights for streamlining logistics\, implementing digital platforms and optimizing patient operations to establish a reliable global delivery of cell therapies? \nThen look no further! The 3rd Supply Chain & Logistics for Cell Therapies Summit is back and taking place in-person for the first time this 25-27 April 2022! \nView the full 3-day agenda here: https://ter.li/yp10r2 \n2022 Agenda Overview: \nWith exclusive presentations and interactive talks on key industry challenges\, gain valuable takeaways from leaders in the field from GlaxoSmithKline\, Legend Biotech\, Iovance\, Gamida Cell\, and more. Discuss standardization\, review digital system implementation\, prepare for upscaling and optimize cryopreservation in person with like-minded supply chain professionals all to maximize efficiency and create a patient-centric end-to-end system. \nDownload the full event guide to learn more about our speakers\, agenda topics\, and face-to-face networking opportunities. https://ter.li/yp10r2
URL:https://www.pharmajournalist.com/event/3rd-supply-chain-and-logistics-for-cell-therapies-summit/
LOCATION:Crowne Plaza Boston – Woburn\, an IHG Hotel\, 15 Middlesex Canal Park Rd\, Woburn\, MA\, 01801\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220426
DTEND;VALUE=DATE:20220429
DTSTAMP:20260516T014342
CREATED:20211213T100512Z
LAST-MODIFIED:20220316T101306Z
UID:32486-1650931200-1651190399@www.pharmajournalist.com
SUMMARY:2nd Ligase Targeting Drug Development Summit
DESCRIPTION:Whilst the exploiting of this therapeutic modality surges through biopharma and academia\, it is essential that we unlock the fundamental challenges within this industry\, as this remains a key factor determining success of degraders in the clinic. \n \nThe 2nd Ligase Targeting Drug Development Summit returns to Boston in April again uniting industry frontiers and leading minds\, as together we discuss\, update\, and learn how to successfully hijack ligases for therapeutic application\, and uncover a critical piece of the puzzle in realizing the full potential of this therapeutic approach. \nFilling the gap of an industry-led ubiquitin discussion\, we again provide an unrivalled forum to unite leading biopharmaceutical giants\, alongside key academics\, to share unseen data\, collaborative efforts and discuss next steps to successfully select\, validate and translate E3’s into a viable therapy. \nJoin us in Boston to expand your understanding of the ever-broadening ligases field and the fast-improving chemical biology tools to seize the therapeutic value of Ubiquitin E3 ligases and differentiate your pipelines. \nTo Know more visit: https://ter.li/rm8y7d
URL:https://www.pharmajournalist.com/event/2nd-ligase-targeting-drug-development-summit/
LOCATION:Online\, EDT
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220426
DTEND;VALUE=DATE:20220428
DTSTAMP:20260516T014342
CREATED:20220117T082710Z
LAST-MODIFIED:20220127T121445Z
UID:32823-1650931200-1651103999@www.pharmajournalist.com
SUMMARY:Reuters Events: Digital Health 2022
DESCRIPTION:Join the world’s leading forum for advancing the delivery of digital care \nDigital Health’s deployment has been as fast as it has wide. Overnight it has become the central focus for hospitals\, clinics and health plans across the nation. The result? Workflows are more complicated than ever. We’re failing on patient engagement. And we still lack a clearly defined digital care payment infrastructure. \nNow is the moment to tackle inefficiencies in our use of digital health or risk sub-optimal becoming the new norm. We must not squander the biggest opportunity for the industry’s advancement in half a century. \nThat’s why we’ve created Reuters Events Digital Health – the place where the standard is set by 300+ executives for the delivery of quality virtual\, predictive\, affordable and equitable care. Our world-leading forum is where leaders of health systems\, payers\, policy makers\, pharma and health tech converge to realize the transformative potential of technology in healthcare.
URL:https://www.pharmajournalist.com/event/reuters-events-digital-health-2022/
LOCATION:Mission Bay Resort\, San Diego\, California
ORGANIZER;CN="Reuters Events":MAILTO:jack.tiplady@thomsonreuters.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220426
DTEND;VALUE=DATE:20220429
DTSTAMP:20260516T014342
CREATED:20220125T093551Z
LAST-MODIFIED:20220125T093551Z
UID:32942-1650931200-1651190399@www.pharmajournalist.com
SUMMARY:5th Neoantigen Summit Europe
DESCRIPTION: The 5th Neoantigen Summit Europe\, the definitive industry meeting for uncovering the full potential of neoantigens in creating individualised neoantigen vaccines is returning in person! \nFrom understanding the latest clinical insights to reviewing vaccines post-COVID\, our 35+ expert speakers and 3-day agenda developed alongside #Vaccibody\, #Gritstonebio\, #Targovax\, #Vaximm\, #Immunetune and #OdimmaTherapeutics will help you advance your pipeline to successfully weaponise neoantigens for anti-tumour treatment. \nJoin 100+ colleagues and take on the next frontier in neoantigen identification and vaccine manufacturing. \nKey speakers include: Agnete Fredriksen\, Chief Innovation & Strategy Officer\, Nykode Therapeutics | Barbara Loesch\, Head of Technology and Innovation\, Medigene |Jessica Matta\, Co-Founder & Chief Executive Officer & Chief Scientific Officer\, Odimma therapeutics | Andrew Allen\, CEO\, Gritstone bio | Peter Sondermann\, CEO\, Tacalyx GmbH |Sijme Zeilemaker\, Chief Executive Officer\, Immunetune \nFind out more in the event guide here: https://ter.li/gulg78 \nVisit the official event website here: https://ter.li/s89k61
URL:https://www.pharmajournalist.com/event/5th-neoantigen-summit-europe/
LOCATION:Leonardo Royal Amsterdam\, Paul van Vlissingenstraat 24\, Amsterdam\, 1096 BK\, Netherlands
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220426
DTEND;VALUE=DATE:20220429
DTSTAMP:20260516T014342
CREATED:20220201T115212Z
LAST-MODIFIED:20220201T115212Z
UID:33082-1650931200-1651190399@www.pharmajournalist.com
SUMMARY:6th R&D Sourcing & Procurement Summit in Pharma
DESCRIPTION:We are excited for the 6th Advanced R&D Procurement & Sourcing in Pharma Summit returning to Boston in April\, reuniting senior leaders to share their stories and lessons learned\, and how they implement strategic sourcing to optimize spending and mitigate risks. \nAs the one and only community dedicated to 100+ R&D procurement\, category management\, and sourcing professionals\, this is your must-attend conference in 2022 to benchmark your SOPs against your peers and stay at the forefront of technology to streamline your procurement processes. Leave this meeting with practical tips to drive scientific innovations with sustainability\, optimized spend and strengthened vendor relationships! \nYour Unmissable Spotlight Case Studies In 2022: \n\nEstablish robust external supplier relationship models to advance your pipeline development with Betrand Rosier\, Global Procurement Head\, Sanofi\nRebrand procurement to be your scientists’ best business partner with Gerard Cardillo\, Vice President\, Global Procurement\nExplore lessons learned from COVID including strategic investing with Sean Cumbie\, Vice President\, Global Sourcing & Procurement\, NOVAVAX\nDevelop sourcing & procurement strategies at lightspeed with James Tornos\, Vice President\, Sourcing & Enterprise Services – Research\, Development and Medical Procurement\, Pfizer\nDeep-dive into driving D&I initiatives\, both within companies and through supplier diversity initiatives in an exclusive\, interactive workshop led by Manuele Burdese\, Senior Director\, Head of Business Insights & Analytics Strategic Sourcing & Procurement\, Bristol Myers Squibb\, Tom Thattacherry\, Head\, Supplier Diversity\, Genentech\n\nTo find out how you and your team can get involved download your free event guide or get in touch.
URL:https://www.pharmajournalist.com/event/6th-rd-sourcing-procurement-summit-in-pharma/
LOCATION:The Bostonian Boston\, 26 NORTH STREET\, BOSTON\, MA\, 02109\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:monica.mojumder-chan@hansonwade.com
END:VEVENT
END:VCALENDAR